Literature DB >> 17370055

[Hypertonic saline solution for reduction of intracranial pressure. Are there doubts?].

H Theilen1, M Ragaller, T Koch.   

Abstract

Osmotherapy, i.e. the intravenous administration of hyperosmolar solutions, is one of the mainstays of therapy for reduction of a pathologically increased intracranial pressure, in addition to analgosedation and raising the upper body of the patient. The administration of mannitol as a osmotherapeutic agent is, however, marred by considerable side-effects. A possible alternative is the use of hypertonic saline solution (NaCl). The advantages and disadvantages of this option are considered as well as points still in question.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17370055     DOI: 10.1007/s00101-007-1160-6

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  10 in total

Review 1.  Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications.

Authors:  S I Rapoport
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

Review 2.  [Small-volume resuscitation for hypovolemic shock. Concept, experimental and clinical results].

Authors:  U Kreimeier; F Christ; L Frey; O Habler; M Thiel; M Welte; B Zwissler; K Peter
Journal:  Anaesthesist       Date:  1997-04       Impact factor: 1.041

3.  Qualitative evaluation of the blood-brain barrier after the use of hypertonic saline solution in young rats.

Authors:  R M Carrera; A M Pacheco; R A Mastroti
Journal:  Eur Surg Res       Date:  2001 Sep-Dec       Impact factor: 1.745

4.  Effect of duration of osmotherapy on blood-brain barrier disruption and regional cerebral edema after experimental stroke.

Authors:  Chih-Hung Chen; Thomas J K Toung; Adam Sapirstein; Anish Bhardwaj
Journal:  J Cereb Blood Flow Metab       Date:  2005-11-23       Impact factor: 6.200

5.  Treatment of resistant intracranial hypertension with hypertonic saline. Report of two cases.

Authors:  L I Worthley; D J Cooper; N Jones
Journal:  J Neurosurg       Date:  1988-03       Impact factor: 5.115

6.  Plasma arginine-vasopressin following experimental stroke: effect of osmotherapy.

Authors:  Yi Chang; Tsung-Ying Chen; Chih-Hung Chen; Barbara J Crain; Thomas J K Toung; Anish Bhardwaj
Journal:  J Appl Physiol (1985)       Date:  2005-12-08

Review 7.  The use of hypertonic saline for treating intracranial hypertension after traumatic brain injury.

Authors:  Hayden White; David Cook; Bala Venkatesh
Journal:  Anesth Analg       Date:  2006-06       Impact factor: 5.108

8.  Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: Effect on intracranial pressure and lateral displacement of the brain.

Authors:  A I Qureshi; J I Suarez; A Bhardwaj; M Mirski; M S Schnitzer; D F Hanley; J A Ulatowski
Journal:  Crit Care Med       Date:  1998-03       Impact factor: 7.598

9.  Fluorescence labeling of the capillary network in rat brains.

Authors:  H Theilen; W Kuschinsky
Journal:  J Cereb Blood Flow Metab       Date:  1992-03       Impact factor: 6.200

10.  Hypertonic sodium resuscitation is associated with renal failure and death.

Authors:  P P Huang; F S Stucky; A R Dimick; R C Treat; P Q Bessey; L W Rue
Journal:  Ann Surg       Date:  1995-05       Impact factor: 12.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.